Masimo Corporation
Masimo Corporation
MASI
Valuace
78
Růst
31
Zdraví
74
Cena
$ 145.13
Dnes
+2.18 (1.56%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
7.8B
Obrat
2B
Zisk
0B
Aktiva
2B
Dluh
1B
ROE
-70%
ROA
-31%
PE
-13
PS
4
Cena 1R
126-195
⌀ Cena
150.41
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
26-02-2026
Poslední dividenda

Profil

Masimo Corporation vyvíjí, vyrábí a prodává neinvazivní monitorovací technologie a řešení pro automatizaci nemocnic po celém světě. Společnost nabízí technologii masimo Signální extrakce (SET) pulzní oximetrie s měřením průchozího pohybu a monitorováním nízké perfuzní pulzní oximetrie pro řešení primárních omezení konvenční pulzní oximetrie. Poskytuje také Masimo rainbow SET platformu, která zahrnuje duhový SET Pulse CO-Oximetry produkty, které neinvazivně monitorují hemoglobinové druhy, včetně nasycení kyslíkem, pulzní rychlosti, perfuzního indexu, indexu variability pleth a rychlosti dýchání z plethu; neinvazivně monitorují koncentraci hemoglobinu a karboxyhemoglobinu a methemoglobinu; monitorují arteriální nasycení kyslíkem a akustickou rychlost dýchání; a vypočítávají obsah kyslíku a index kyslíkových rezerv. Nabízí technologii SedLine pro monitorování funkce mozku pro měření elektrické aktivity mozku detekcí EEG signálů; produkty pro monitorování kapnografie a plynu zahrnující externí plug-in-and-measure capnografii a analyzátory plynu, integrované moduly, ruční kapnografové a kapnografické přístroje a odběrné linky pro měření kapnografie; O3 regionální oximetrii pro měření saturace tkáňovým kyslíkem; a hemodynamická monitorovací řešení. Jeho Masimo Hospital Automation platforma zahrnuje Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60 a MyView. Nabízí propojovací zařízení, a nosní ventilaci s vysokým průtokem a řešení neuromodulace. Své produkty poskytuje prostřednictvím přímého prodeje, distributorů a partnerů výrobců originálních zařízení nemocnicím, poskytovatelům zdravotnických služeb a domácí péče, zařízením dlouhodobé péče, lékařským ordinacím, veterinárním lékařům a spotřebitelům a výrobkům, které nejsou zdravotnickými ani spotřebitelskými, prostřednictvím internetových stránek elektronického obchodu masimopersonalhealth.com. Společnost byla založena v roce 1989 a sídlí v Irvine v Kalifornii.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
3600
Založení
2007-08-08
Adresa
52 Discovery
CEO
Catherine M. Szyman

Podobné společnosti

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues1,526.91,526.92,094.42,048.12,035.81,239.21,143.7937.8858.3798.1694.6630.1586.6547.2493.2439.0405.4
Cost of Revenues581.7581.71,090.01,044.6977.0430.8400.7308.7283.4263.0230.8220.1195.9188.4167.0144.9119.8
Gross Profit945.2945.21,004.41,003.51,058.8808.3743.1629.2574.9535.1463.8410.0390.8358.8326.3294.1285.6
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues412.5371.5370.9372.0600.7504.6343.9339.6548.9478.9
Cost of Revenues165.2140.9137.6138.0356.0241.4136.6133.0286.2244.1
Gross Profit247.3230.6233.3234.0244.7263.2207.3206.6262.7234.8
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0175.2191.4137.2118.793.377.062.059.456.656.655.647.138.436.0
Selling General & Admin Expenses0.00.00.0664.0657.4395.3369.1314.7289.5275.8253.7252.7241.0215.5193.9169.2143.4
Depreciation & Amortization38.838.8103.098.3136.135.628.423.521.120.116.815.712.811.49.47.36.6
Total Operating Expenses635.2632.41,271.1867.0848.8532.5487.7408.0366.4337.7313.0309.3297.6271.1241.0207.6179.4
Operating Income310.0312.8-266.7136.5210.0275.8255.8221.2208.0197.4420.8120.3103.579.785.286.5104.9
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.038.046.5
Selling General & Admin Expenses0.00.00.00.00.00.00.00.0159.8156.1
Depreciation & Amortization13.68.28.48.630.851.810.410.022.524.5
Total Operating Expenses163.4147.0168.8156.0603.8233.1165.4153.5197.8202.6
Operating Income83.983.664.578.0-359.130.141.953.164.925.2
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income3.53.44.83.01.80.95.513.90.00.00.00.00.00.00.00.00.0
Interest Expense33.333.243.650.325.70.40.30.3-4.9-2.0-537.6-37.1-17.317.41.10.3-2.8
Other Expense-37.3-40.2-38.6-48.4-16.6-1.47.913.05.32.0267.615.78.9-12.0-1.40.01.3
IBT272.7272.6-305.388.1193.4274.4263.7234.2213.8199.4418.3116.3102.075.783.886.5107.6
Income Tax Expense65.064.9-0.46.649.944.723.538.020.267.8117.734.827.720.021.922.534.2
Net Income-151.5-151.5-304.981.5143.5229.6240.3196.2193.5131.6300.783.372.558.462.363.773.5
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income0.80.70.61.41.11.31.21.20.80.7
Interest Expense7.58.88.28.810.010.511.012.013.812.8
Other Expense-9.9-8.7-9.1-9.6-2.6-18.5-11.1-11.6-20.9-11.2
IBT74.074.955.468.4-361.711.630.841.523.214.0
Income Tax Expense12.121.210.521.2-12.11.86.09.4-10.83.4
Net Income68.3-100.451.3-170.7-349.69.816.018.933.910.6
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$1.54$2.68$4.16$4.39$3.67$3.70$2.42$6.28$1.62$1.33$1.03$1.08$1.07$1.25
EPS Diluted$0.00$0.00$0.00$1.51$2.60$3.98$4.14$3.44$3.45$2.23$5.85$1.55$1.30$1.02$1.07$1.05$1.21
Shares Outstanding53.653.653.352.853.655.254.753.452.351.549.551.354.756.757.459.758.8
Diluted Shares Outstanding54.254.253.354.155.257.758.057.156.055.953.253.755.657.558.460.860.6
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.64$0.20
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.63$0.20
Shares Outstanding53.654.054.054.053.653.453.153.052.852.8
Diluted Shares Outstanding54.254.454.854.853.654.354.354.253.753.9
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents132.4177.6163.0202.9745.3641.4567.7552.5315.3306.0132.3134.595.571.6129.988.3
Short Term Investments0.00.00.00.00.00.0120.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments132.4177.6163.0202.9745.3641.4687.7552.5315.3306.0132.3134.595.571.6129.988.3
Accounts Receivable406.1489.3421.0445.9200.8141.4132.4109.6121.3101.781.078.684.175.064.161.7
Inventory513.0459.2545.0501.0201.4216.0115.993.895.972.562.069.756.847.445.945.0
Other Current Assets90.799.7102.9158.891.0102.460.129.228.126.021.44.12.83.92.02.1
Total Current Assets1,142.21,225.81,231.91,308.61,238.41,101.2996.1785.1564.1507.2299.1315.1271.8219.3262.9217.6
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents314.7149.6130.8177.6158.5129.6149.5166.0124.4150.7
Short Term Investments0.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments314.7149.6130.8177.6158.5129.6149.5166.0124.4150.7
Accounts Receivable355.9352.5346.6489.3444.6406.1401.0421.0420.5408.8
Inventory338.6318.5301.2459.2569.9513.0506.1545.0584.6542.6
Other Current Assets39.1449.2405.499.7106.993.5109.0102.9108.0106.1
Total Current Assets1,048.31,269.81,184.01,225.81,279.91,142.21,165.61,231.91,237.51,208.2
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment491.4456.0483.5402.5272.8272.5219.6166.0164.1136.0132.5102.024.923.915.216.0
Goodwill389.096.7407.7445.4100.3103.222.423.320.619.820.421.022.822.80.40.4
Intangible Assets606.1558.2652.3722.672.573.927.327.927.129.427.627.828.127.411.410.5
Long-Term Investments112.28.6111.913.813.88.06.51.21.279.966.867.561.752.151.747.2
Other Long-Term Assets46.0136.847.0215.2136.5114.488.5130.1109.19.211.07.56.88.07.66.0
Total Long-Term Assets1,751.71,399.91,809.61,902.0648.6611.4400.1369.7346.1313.3302.6249.9166.9156.6103.292.6
Total Assets2,893.92,625.73,041.53,210.61,887.01,712.61,396.11,154.8910.2820.5601.7565.0438.7375.9366.1310.2
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment345.3364.1359.8456.0501.0490.0490.1485.0415.0410.0
Goodwill100.8100.998.396.7412.5389.0396.0407.7400.1410.9
Intangible Assets56.7116.460.5558.2640.8606.1635.91,204.6630.0665.7
Long-Term Investments48.58.07.98.69.49.29.5111.9124.613.9
Other Long-Term Assets98.6482.8462.9136.8137.1150.4153.5-506.8100.5214.1
Total Long-Term Assets769.21,191.51,108.61,399.91,807.91,751.71,792.11,809.61,758.41,803.0
Total Assets1,817.52,402.62,293.12,625.73,087.82,893.92,957.73,041.52,995.93,011.2
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable216.0252.8251.5276.875.664.154.540.433.831.125.938.028.027.027.322.2
Short-Term Debt55.258.770.733.86.46.04.749.50.00.10.10.10.10.10.00.1
Other Current Liabilities237.5203.9188.1238.8134.9118.987.124.681.9151.085.464.754.943.232.631.6
Current Liabilities546.2617.7563.8630.0267.7233.8172.2147.6151.6220.4132.6123.9103.889.576.070.2
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable117.9135.7124.9252.8280.8216.0203.1251.5283.5265.5
Short-Term Debt7.722.923.858.761.955.253.970.746.349.5
Other Current Liabilities206.1357.0324.8203.9199.5189.9161.5188.1192.6189.0
Current Liabilities369.7592.1546.5617.7637.6546.2504.2563.8578.8571.9
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt746.5787.4917.5941.626.328.415.869.9-9.9-0.3185.1125.90.22.00.10.1
Capital Leases61.780.964.072.132.734.320.50.00.00.10.11.00.32.10.10.2
Def. Tax Liability130.9100.1136.1163.65.16.23.13.09.90.30.224.20.08.10.00.0
Total Liabilities1,525.11,573.81,676.71,871.7336.8304.9228.3185.8203.3260.3326.0257.3112.3100.386.480.2
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt578.5619.3657.7787.4799.0808.2902.9917.5953.1935.9
Capital Leases0.028.530.580.988.361.780.845.860.064.8
Def. Tax Liability29.60.20.2100.1111.3102.1106.9136.1112.1118.9
Total Liabilities1,007.51,359.81,346.71,573.81,624.61,525.11,592.51,676.71,720.31,702.9
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock0.10.10.10.10.10.10.10.10.10.10.10.10.10.10.10.1
Retained Earnings1,830.71,490.91,795.81,714.31,570.91,341.21,100.5931.1720.8589.2288.6205.3132.774.469.45.7
Comprehensive Income-103.4-108.2-45.311.5-5.51.4-6.7-6.2-2.9-7.0-4.7-2.14.03.51.30.9
Total Common Equity1,368.81,051.91,364.81,338.91,550.21,407.71,167.9969.1706.9560.2275.4306.0326.5273.1276.8227.6
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.10.10.10.10.10.10.10.10.10.1
Retained Earnings1,271.11,371.51,320.21,490.91,840.51,830.71,814.71,795.81,761.91,751.3
Comprehensive Income-13.4-49.0-86.1-108.2-36.6-103.4-75.3-45.3-90.9-47.6
Total Common Equity810.01,042.8946.41,051.91,463.21,368.81,365.21,364.81,275.61,308.3
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt863.4846.1970.0975.432.734.320.50.00.00.1185.1126.00.32.10.10.2
Book Value1,368.81,051.91,364.81,338.91,550.21,407.61,167.9969.1706.9560.2275.7307.7326.4275.7279.7230.0
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value810.01,042.8946.41,051.91,463.21,368.81,365.21,364.81,275.61,308.3
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income79.5-151.5-304.981.5143.5229.6240.3196.2193.5131.6300.781.574.455.761.964.173.4
Depreciation & Amortization95.238.8103.098.3136.135.629.323.521.120.116.815.712.811.49.47.36.6
Stock-Based Compensation31.435.841.57.047.744.642.239.227.417.212.510.811.011.714.113.712.3
Change Working Capital6.3-89.9-10.7-70.9-261.8-31.3-96.5-32.47.2-146.080.88.2-4.0-18.9-7.4-9.4-36.3
Change In Accounts Receivable20.117.2-60.291.9-138.5-60.8-2.2-23.610.8-19.8-21.2-9.94.9-9.6-10.1-7.5-10.9
Change In Accounts Payable-30.3-27.114.8-19.660.511.07.69.95.2-4.17.8-4.3-1.41.0-1.75.25.5
Change In Inventories-16.1-112.1-7.5-69.2-155.913.5-94.4-21.3-1.9-22.9-10.87.5-13.4-9.5-0.5-3.0-14.1
Other Non-cash Items69.9372.2405.713.83.31.30.61.0-1.511.30.6-2.11.32.33.94.97.2
Cash from Operations190.40.00.094.129.5264.8211.0221.6239.558.1416.8114.295.554.375.479.061.0
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income497.753.744.947.2-349.6-12.224.832.134.010.6
Depreciation & Amortization13.68.18.48.630.851.810.410.022.524.5
Stock-Based Compensation8.90.08.59.111.99.011.98.79.4-1.1
Change Working Capital-31.7-18.5-6.1-33.6-8.1-9.119.3-12.843.2-49.7
Change In Accounts Receivable18.46.7-3.9-4.0-57.95.66.0-13.913.9-11.1
Change In Accounts Payable-13.5-16.38.8-6.1-14.646.0-8.8-7.8-23.215.4
Change In Inventories-49.4-31.0-25.1-6.632.6-35.4-7.52.823.9-47.6
Other Non-cash Items-433.913.513.7-6.1365.5-13.98.17.83.60.5
Cash from Operations0.00.00.00.00.00.00.00.077.1-7.0
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-79.3-19.4-20.0-44.0-56.3-34.9-80.0-72.5-22.7-46.8-24.4-54.6-78.4-13.0-14.5-7.5-11.5
Acquisitions18.30.00.07.5-999.70.0-116.10.0-3.90.0-0.80.00.00.0-37.40.01.9
Investments0.00.00.00.00.00.0-7.4-125.20.0-1.10.00.00.00.00.00.0-76.0
Sales of Investment0.00.00.00.00.00.0120.00.00.00.00.00.00.00.00.00.0133.0
Other Investing Activities-2.60.00.0-44.7-1.6-2.60.70.00.50.00.00.00.00.00.00.0-1.9
Cash from Investing-68.90.00.0-81.2-1,057.6-37.5-82.8-197.7-26.2-47.9-25.1-54.6-78.4-13.0-51.9-7.545.5
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-7.1-7.1-3.8-2.64.5-14.8-3.6-6.1-25.3-22.1
Acquisitions0.00.00.00.00.00.00.00.07.50.0
Investments0.00.00.00.00.00.00.00.00.00.0
Sales of Investment0.00.00.00.00.00.00.00.00.00.0
Other Investing Activities0.00.00.00.00.00.00.00.0-7.5-0.3
Cash from Investing0.00.00.00.00.00.00.00.0-25.3-22.4
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-199.90.00.0-51.2-135.40.00.00.00.0-0.1-230.1-70.1-0.1-0.10.0-0.1-0.1
Debt Issued174.5846.1-123.945.81,078.1-1.713.920.50.00.045.0129.3125.7-1.62.00.00.2
Issuance of Common Stock10.90.00.07.08.123.258.428.344.762.237.328.34.73.31.65.910.2
Repurchase of Common Stock-6.0-363.70.00.0-401.5-128.9-110.5-37.6-18.5-66.3-68.2-150.2-102.5-19.8-26.3-36.20.0
Dividends Paid0.00.00.00.00.00.00.00.00.0-0.1-45.0-130.0-125.00.0-57.30.0-162.0
Other Financing Activities54.50.00.0-12.91,049.1-16.7-2.2-0.1-0.50.189.4262.9249.1-1.3-0.20.10.7
Cash from Financing-134.50.00.0-57.1520.3-122.4-54.3-9.325.8-4.1-216.6-59.126.2-17.9-82.1-30.2-151.1
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-36.418.6
Debt Issued586.2-56.0-39.3-164.6-14.8-2.5-93.4-13.296.339.9
Issuance of Common Stock0.00.00.00.00.00.00.00.00.30.7
Repurchase of Common Stock-186.7-163.3-13.70.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.0-0.20.0
Cash from Financing0.00.00.00.00.00.00.00.0-36.319.3
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-19.526.013.2-41.4-538.8103.476.915.4237.27.3173.7-2.139.023.9-58.341.6-43.7
Closing Cash Balance132.4152.3181.4168.2209.6748.4645.0568.1552.6315.5306.0132.3134.595.571.6129.988.3
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash-162.4162.420.6-4.917.728.1-28.4-4.239.2-26.3
Closing Cash Balance152.3314.7197.1176.5181.4163.7135.6164.0166.0132.3
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow111.1197.8145.36.4-26.8229.8131.0149.1216.811.3392.559.617.041.360.971.449.5
Real Free Cash Flow79.7162.0103.8-0.6-74.5185.288.8109.9189.4-5.8380.048.86.029.646.857.837.2
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow53.450.964.527.047.5-4.767.435.151.8-29.1
Real Free Cash Flow44.550.956.017.935.6-13.755.526.442.4-28.0
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-12.735.51703.4
P/S4.25.967.9
P/B8.9725.8
P/FCF45.142.1396.3
Market cap$7.8$6.9
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets32.3 %11.3 %0 %
Debt to Income-386.9 %165.5 %0 %
Debt to Free cash flow346.2 %14843.4 %0 %
Interest expense percentage10.7 %-4.2 %38.7 %
Current ratio2.8 3.4 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-18.7 %16.5 %0 %
ROA-8.3 %12.2 %0 %
CapEx to Revenue0.5 %4.6 %10.6 %
RaD to Revenue0 %9.3 %0 %
ROEM424,138.9 222839.7

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin55 %63.3 %79.8 %
Operating margin-7.8 %19.7 %29.6 %
Net margin-33.2 %14 %27.3 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %1.8 %0 %
Dividend payout percentage0 %49.3 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding54.4 mil 56.4 mil
Employee count3.6 tis 1.9 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader